Civitas Solutions ROE 2012-2018 | CIVI

Current and historical return on equity (ROE) values for Civitas Solutions (CIVI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Civitas Solutions ROE for the three months ending December 31, 2018 was 36.04%.
Civitas Solutions ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.01B $0.17B 7.08%
2018-09-30 $0.02B $0.17B 8.82%
2018-06-30 $0.01B $0.17B 3.55%
2018-03-31 $0.00B $0.17B 1.77%
2017-12-31 $0.01B $0.18B 5.95%
2017-09-30 $0.01B $0.16B 3.07%
2017-06-30 $0.02B $0.17B 11.99%
2017-03-31 $0.02B $0.16B 11.28%
2016-12-31 $0.02B $0.15B 13.17%
2016-09-30 $0.01B $0.15B 6.52%
2016-06-30 $0.01B $0.14B 7.59%
2016-03-31 $0.01B $0.14B 4.74%
2015-12-31 $0.00B $0.13B 0.82%
2015-09-30 $0.00B $0.12B 3.40%
2015-06-30 $-0.01B $0.12B -5.15%
2015-03-31 $-0.01B $0.12B -8.09%
2014-12-31 $-0.02B $0.11B -36.68%
2014-09-30 $-0.02B $0.12B -79.31%
2014-06-30 $-0.02B $0.00B 144.68%
2014-03-31 $-0.02B $0.00B 88.31%
2013-12-31 $-0.01B $0.00B 25.97%
Sector Industry Market Cap Revenue
Medical Medical Services $0.643B $1.602B
Civitas Solutions, Inc. is a national network of local health and human services. It operates as a provider of an array of community-based services to adults and children with intellectual and developmental disabilities, brain and spinal cord injuries and other catastrophic injuries and illnesses, and to youth with emotional, behavioral and medically complex challenges, as well as their families. The Company serves governmental agencies, non-public payors, and not-for-profit organizations. Civitas Solutions, Inc. is based in Boston, Massachusetts.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.892B 23.96
PRA Health Sciences (PRAH) United States $7.401B 30.21
Charles River Laboratories (CRL) United States $6.832B 23.53
HealthEquity (HQY) United States $4.992B 97.57
NovoCure (NVCR) Jersey $4.949B 0.00
Premier (PINC) United States $4.926B 16.70
Teladoc (TDOC) United States $4.872B 0.00
BioTelemetry (BEAT) United States $2.510B 44.34
AMN Healthcare Services Inc (AMN) United States $2.510B 16.28
Medpace Holdings (MEDP) United States $2.500B 30.93
Intrexon (XON) United States $1.091B 0.00
CareDx (CDNA) United States $1.045B 0.00
Natera (NTRA) United States $1.000B 0.00
Healthways (TVTY) United States $0.901B 9.56
China Cord Blood (CO) China $0.825B 22.63
Apollo Medical Holdings (AMEH) United States $0.668B 0.00
Surgery Partners (SGRY) United States $0.624B 0.00
Establishment Labs Holdings (ESTA) $0.539B 0.00
OncoCyte (OCX) United States $0.196B 0.00
Imprimis Pharmaceuticals (HROW) United States $0.156B 0.00
Interpace Diagnostics (IDXG) United States $0.027B 0.00
OpGen (OPGN) United States $0.012B 0.00
Cancer Genetics (CGIX) United States $0.007B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.002B 0.00